The allotment of Senores Pharmaceuticals shares is set to be finalised today (December 26). An Ahmedabad-based pharma company’s Rs 582.11-crore public issue opened for subscription from December 20 to December 24. On the final day of its bidding window, Senores Pharmaceuticals IPO received a subscription of 93.41 times.
The IPO was priced in a band of Rs 372 to Rs 391 per share, with a minimum lot size of 38 shares.
How to Check Allotment Status
Investors can check their allotment status through multiple platforms such as NSE, BSE and also through the registrar’s website Link Intime. Here is the step-by-step guide to check your allotment status on each website.
Via NSE
Visit the NSE Website
Create an account by registering with your details or log in if you already have one.
Find and choose “Senores Pharma” from the list of IPOs available.
Enter your details such as IPO application number or other required information.
Hit the “Submit” button, and your allotment status will be displayed on the screen
Via BSE
Visit the BSE website and navigate to the “Investor Services” section
From the dropdown menu, select “Status of Issue Application” to proceed
In the issue type, select “Equity” to specify the IPO category
Enter your IPO application details, including the “Issue Name” and your PAN number
Click the “Search” button, and your IPO allotment status will appear on the screen
Via Link Intime
Visit Link Intime website
Select the company name
Enter PAN, application number, or DP Client ID
Click on “Submit” to view allotment details
Senores Pharmaceuticals IPO – GMP
Ahead of the listing of the mainboard IPO on the Indian bourses, the shares of the company in the grey market is currently trading at a premium of Rs 240, indication of a potential listing at Rs 631, a 61.38 per cent gain from the issue’s upper price band of Rs 391.
However, it is also important to note that GMP is not the official price as it is an unlisted marketplace and may not reliably reflect the actual listing price.
Subscription breakdown
Investors flocked to bid for 79.72 crore shares, a demand far surpassing the available 85.34 lakh shares. Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs) led the charge, while the retail segment received a subscription rate of 89.23 times.
